Peptide therapy — the use of short amino acid chains to signal specific biological processes — has moved from bodybuilding underground circles to mainstream longevity clinics. The peptide market grew 30% in 2023 and is projected to reach $48 billion by 2030. But with dozens of compounds available through grey-market sources and a rapidly evolving regulatory landscape, consumers need a clear-eyed guide.
What Are Peptides?
Peptides are chains of 2–50 amino acids that act as biological messengers. Your body makes thousands of them naturally — insulin is a peptide, as are many hormones and growth factors. Therapeutic peptides either mimic naturally occurring signaling molecules or modify their action, typically with high target specificity and a favorable safety profile compared to small-molecule drugs.
The Most Researched Peptides
BPC-157 (Body Protection Compound)
Derived from a protein found in gastric juice, BPC-157 shows remarkable tissue-healing properties in animal models — accelerating tendon, ligament, and gut healing. Human data is limited to case reports and small trials, but the mechanism is well-understood: BPC-157 upregulates growth hormone receptor expression and promotes angiogenesis (new blood vessel formation) in damaged tissue.
TB-500 (Thymosin Beta-4)
TB-500 promotes actin polymerization, cell migration, and wound healing. Used extensively in veterinary medicine (particularly in racehorses), it’s gaining traction among athletes for injury recovery. The anti-fibrotic effects are particularly interesting for chronic tendinopathy and scar tissue.
CJC-1295 / Ipamorelin (GH Secretagogues)
These peptides stimulate growth hormone release from the pituitary without the side effects associated with exogenous GH administration. The combination produces GH pulses that improve body composition, sleep quality, and recovery. Unlike GH itself, they work through natural regulatory feedback — so GH output doesn’t suppress natural production.
The Regulatory Reality
Most therapeutic peptides exist in a regulatory grey zone. They’re not FDA-approved drugs (except for specific indications), but they’re also not supplements. Compounding pharmacies can produce them legally for research use, but quality varies dramatically. Recent FDA crackdowns on compounded semaglutide illustrate the direction of regulatory travel — sourcing from reputable compounding pharmacies with third-party testing is non-negotiable.
Who Should Consider Peptides
Peptide therapy is most appropriate under physician supervision for specific goals — injury recovery, age-related GH decline, or gut healing. Self-administering compounds sourced from research chemical suppliers carries real risks of contamination, incorrect dosing, and unknown long-term effects. The best outcomes come from personalized protocols developed with a longevity physician who can monitor bloodwork and adjust accordingly.